Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    DUAL-2
Show Display Options
Rank Status Study
1 Terminated
Has Results
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Conditions: Systemic Sclerosis;   Ulcers
Interventions: Drug: macitentan 3mg;   Drug: macitentan 10mg;   Drug: placebo

Study has passed its completion date and status has not been verified in more than two years.